Suppr超能文献

miR-223 在 COPD 患者的肺部中增加,并调节香烟烟雾引起的肺部炎症。

MiR-223 is increased in lungs of patients with COPD and modulates cigarette smoke-induced pulmonary inflammation.

机构信息

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2021 Dec 1;321(6):L1091-L1104. doi: 10.1152/ajplung.00252.2021. Epub 2021 Oct 20.

Abstract

Since microRNA (miR)-223-3p modulates inflammatory responses and chronic obstructive pulmonary disease (COPD) is associated with amplified pulmonary inflammation, we hypothesized that miR-223-3p plays a role in COPD pathogenesis. Expression of miR-223-3p was measured in lung tissue of two independent cohorts with patients with GOLD stage II-IV COPD, never smokers, and smokers without COPD. The functional role of miR-223-3p was studied in deficient mice and on overexpression in airway epithelial cells from COPD and controls. We observed higher miR-223-3p levels in patients with COPD stage II-IV compared with (non)-smoking controls, and levels were associated with higher neutrophil numbers in bronchial biopsies of patients with COPD. MiR-223-3p expression was also increased in lungs and bronchoalveolar lavage of cigarette smoke (CS)-exposed mice. CS-induced neutrophil and monocyte lung infiltration was stronger in miR-223-deficient mice on acute (5 days) exposure, but attenuated on subchronic (4 wk) exposure. Additionally, miR-223 deficiency attenuated acute and subchronic CS-induced lung infiltration of dendritic cells and T lymphocytes. Finally, in vitro overexpression of miR-223-3p in non-COPD airway epithelial cells suppressed C-X-C motif chemokine ligand 8 (CXCL8) and granulocyte monocyte-colony stimulation factor (GM-CSF) secretion and gene expression of the proinflammatory transcription factor Importantly, this suppressive effect of miR-223-3p was compromised in COPD-derived cultures. In conclusion, we demonstrate that miR-223-3p is increased in lungs of patients with COPD and CS-exposed mice and is associated with neutrophilic inflammation. In vivo data indicate that miR-223 acts as negative regulator of acute CS-induced neutrophilic and monocytic inflammation. In vitro data suggest that miR-223-3p does so by suppressing proinflammatory airway epithelial responses, which is less effective in COPD epithelium.

摘要

由于 microRNA (miR)-223-3p 调节炎症反应,而慢性阻塞性肺疾病 (COPD) 与放大的肺部炎症有关,我们假设 miR-223-3p 在 COPD 发病机制中发挥作用。我们在两个独立的队列中测量了 II-IV 期 COPD 患者、从不吸烟的患者和没有 COPD 的吸烟者的肺组织中 miR-223-3p 的表达。在缺乏 miR-223-3p 的小鼠和 COPD 患者和对照组气道上皮细胞的过表达中研究了 miR-223-3p 的功能作用。我们观察到与非吸烟对照组相比,II-IV 期 COPD 患者的 miR-223-3p 水平更高,并且水平与 COPD 患者支气管活检中的中性粒细胞数量相关。在香烟烟雾 (CS) 暴露的小鼠的肺部和支气管肺泡灌洗液中,miR-223-3p 的表达也增加了。在急性 (5 天) 暴露时,缺乏 miR-223 的 CS 诱导的中性粒细胞和单核细胞肺部浸润更强,但在亚慢性 (4 周) 暴露时减弱。此外,miR-223 缺乏减弱了急性和亚慢性 CS 诱导的树突状细胞和 T 淋巴细胞肺部浸润。最后,在非 COPD 气道上皮细胞中的 miR-223-3p 的体外过表达抑制了 C-X-C 基序趋化因子配体 8 (CXCL8) 和粒细胞-单核细胞集落刺激因子 (GM-CSF) 的分泌以及促炎转录因子的基因表达。重要的是,COPD 衍生培养物中 miR-223-3p 的这种抑制作用受到了损害。总之,我们证明 miR-223-3p 在 COPD 患者和 CS 暴露的小鼠的肺部增加,与中性粒细胞炎症有关。体内数据表明,miR-223 作为急性 CS 诱导的中性粒细胞和单核细胞炎症的负调节剂发挥作用。体外数据表明,miR-223-3p 通过抑制促炎气道上皮反应来实现这一点,而在 COPD 上皮中则效果较差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验